How the triglyceride–glucose (TyG) index relates to heart artery imaging in non‑diabetic adults with early coronary artery disease
Official title: Impact of Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients
Run by Sohag University · NCT07154186 · Data updated 2026-11-12
This study will see if the triglyceride–glucose (TyG) index helps explain angiographic patterns in non‑diabetic adults who develop coronary artery disease at younger ages.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | September 4, 2025 |
| Main results expected | February 1, 2026 |
| Study ends | February 1, 2026 |
| Registry record updated | September 5, 2025 |
| Trial ID | NCT07154186 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who are non‑diabetic with angiographically confirmed premature coronary artery disease (before age 55 in men and 65 in women), without prior coronary revascularization and without severe hepatic or renal dysfunction.
✕Probably not a fit
People with known diabetes, prior coronary revascularization, severe liver or kidney disease, active cancer, autoimmune or systemic inflammatory disorders, or those already on triglyceride‑lowering drugs are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study of non‑diabetic patients with premature coronary artery disease confirmed by coronary angiography. Investigators will calculate the TyG index from fasting triglyceride and glucose levels and compare it with angiographic lesion patterns and severity. Patients with known diabetes, prior revascularization, severe liver/kidney dysfunction, malignancy, autoimmune or systemic inflammatory disease, or current triglyceride‑lowering therapy are excluded. The work is conducted at Sohag University and aims to link a low‑cost blood marker of insulin resistance to early atherosclerotic changes on angiography.
Why it matters
Potential benefit: If successful, the TyG index could offer a simple, low‑cost blood marker to help identify insulin‑resistance–related artery disease patterns and guide earlier management in non‑diabetic patients.
How similar studies have gone: Prior observational studies have reported links between higher TyG index values and more severe coronary atherosclerosis, but prospective and interventional evidence remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years old. * Both sexes. * Non-diabetic patients \[no history of diabetes, hemoglobin A1C (HbA1C) \< 6.5%, fasting glucose \< 126 mg/dL\]. * Confirmed diagnosis of coronary artery disease (CAD) by coronary angiography. Exclusion Criteria: * Known diabetes mellitus (type 1 or type 2). * Previous history of coronary revascularization. * Severe hepatic or renal dysfunction \[alanine transaminase (ALT)/aspartate aminotransferase (AST) ≥ 5× upper limit of normal (ULN), estimated glomerular filtration rate (eGFR)\< 30 mL/min/1.73 m²\]. * Malignant disease, autoimmune disease, or systemic inflammatory disorders. * Current use of triglyceride-lowering medications.
Where it's running
-
Sohag University
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Remon S Adly, MD
- Email: remonsaleh@yahoo.com
- Phone: 00201221878986
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.